| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18596737 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 103 journal articles in the PubMed database | Email to a friend | | |
| Finazzi G, Barbui T
Evidence and expertise in the management of polycythemia vera and essential thrombocythemia. [JOURNAL ARTICLE]
Leukemia 2008 Jul 3.
Abstract | Full Citation | Find Related Articles | | Finazzi G, Barbui T
Expertise-Based Management in Essential Thrombocythemia and Polycythemia Vera. [JOURNAL ARTICLE]
Cancer J 2007 November/December; 13(6):372-376.
Abstract | Full Citation | Find Related Articles | | Finazzi G, Barbui T
Risk-adapted therapy in essential thrombocythemia and polycythemia vera. [Journal Article, Review]
Blood Rev 2005 Sep; 19(5):243-52.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Barbui T, Finazzi G
Therapy for polycythemia vera and essential thrombocythemia is driven by the cardiovascular risk. [Journal Article]
Semin Thromb Hemost 2007 Jun; 33(4):321-9.
Abstract | Full Citation | | Solberg LA
Therapeutic options for essential thrombocythemia and polycythemia vera. [Journal Article, Review]
Semin Oncol 2002 Jun; 29(3 Suppl 10):10-5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Finazzi G, Barbui T
How we treat patients with polycythemia vera. [JOURNAL ARTICLE]
Blood 2007 Jan 30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Finazzi G
Risk stratification, staging, and treatment of patients with polycythemia vera: Italian and European collaboration on low-dose aspirin in polycythemia data. [Journal Article]
Semin Thromb Hemost 2006 Apr; 32(3):276-82.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Spivak JL, Barosi G, Tognoni G, et al.
Chronic myeloproliferative disorders. [Journal Article, Review]
Hematology (Am Soc Hematol Educ Program) 2003.:200-24.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Nand S, Stock W, Godwin J, et al.
Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. [Journal Article]
Am J Hematol 1996 May; 52(1):42-6.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
